Quantcast
Last updated on April 17, 2014 at 21:23 EDT

SinoFresh Nasal Spray Achieves Positive Results Against H1N1 (Swine Flu) Virus in Initial Pilot Animal Study

November 19, 2009

VENICE, Fla., Nov. 19 /PRNewswire/ — SinoFresh Healthcare Products, Inc. announced today the successful results of its initial pilot animal study testing the efficacy of the SinoFresh Nasal Spray product when used on animals infected with the H1N1 (“swine flu”) virus. The study data suggests that treatment with SinoFresh allowed the infected animals to recover more rapidly from H1N1 infection than did untreated animals. In addition, pre-treatment with SinoFresh Nasal Spray decreased the severity and/or incidence of infection.

Dr. Michael Stampar, D.O., Senior Medical Advisor to SinoFresh Healthcare Products, stated, “We are very encouraged by this initial study report and will continue to develop data to support our belief that SinoFresh Nasal Spray, a broad based antiseptic solution is an important component in protecting the health of patients that are exposed to the H1N1 (‘swine flu’) virus.”

The study which was conducted by SRS International Corp. of Falls Church VA. was conducted over 14 days and was designed to evaluate the severity of infection from H1N1 (“swine flu”) virus in the Cotton Rat animal model, a well accepted model for studying human nasal and respiratory tract infection by viruses and other microbial pathogens. In this study, the test animals were inoculated with H1N1 and then received SinoFresh Nasal Spray in the nose three times daily for 14 days.

The study evaluated the product’s likelihood of efficacy in both prevention and treatment. One group of animals was treated with SinoFresh Nasal Spray prior to inoculation with H1N1 and a second group was treated starting 15 minutes after inoculation with H1N1 while the remaining “control group” received no treatment during the overall 14 day study period.

The Company has now also initiated a study to evaluate the product’s ability to reduce or eliminate viral shedding which is the main method of transmission of the H1N1 flu virus. The active phase of the additional study has been completed and is in the laboratory for evaluation. Results are expected in the next few weeks.

SinoFresh Healthcare Products, Inc. is a privately held exclusive marketer of innovative upper respiratory system therapies. The Company uses broad-spectrum antiseptic approaches to reduce viral, bacterial, and fungal organisms that are suspected to cause pathogenesis of the mouth, nose, and throat. The Company’s lead product, SinoFresh Nasal Spray, is a hygienic cleansing spray that kills germs and removes other nasal-sinus irritants. This product and a planned series of follow-on products built on the Company’s proprietary technology will, in time, exploit an enormous global opportunity for the SinoFresh product line as people begin to understand the benefit of using a daily preventative antiseptic product that can actually address the causes of diseases in the upper respiratory area.

For further information company can be contacted at 888-460-4774, or on the web at www.sinofreshproducts.com, or by email at customerservice@sinofreshproducts.com.

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.

    SinoFresh Healthcare Products, Inc.
    333 South Tamiami Trail, Suite 286
    Venice, FL 34285

SOURCE SinoFresh Healthcare Products, Inc.


Source: newswire